logo-loader
viewCo-Diagnostics

Full interview: Co-Diagnostics expects to win a CE mark-validated coronavirus diagnostic test by next week

Co-Diagnostics Inc (NASDAQ:CODX) CEO Dwight Egan tells Proactive the Utah-based company expects to achieve a CE mark validation on its coronavirus detection test from the European Union by as early as next week.

Egan says the company is very enthused by the entire process of the development of the test, which he says, graduated from principal design work to a verified test in the company's lab in about 8 days.

Quick facts: Co-Diagnostics

Price: 8.2 USD

NASDAQ:CODX
Market: NASDAQ
Market Cap: $225 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Co-Diagnostics named herein, including the promotion by the Company of Co-Diagnostics in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Bango PLC's Ray Anderson details expanded strategic partnership with NHN Corp

Bango PLC's (LON:BGO) Ray Anderson speaks to Proactive London's Andrew Scott after announcing they've expanded its global data partnership as well as receiving a strategic investment from NHN Corp - a South Korean big data business. NHN will invest £6.5mln into the Audiens data platform,...

1 day, 5 hours ago

2 min read